Related Experiment Video
Updated: Jul 15, 2026
10:04
Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
[Gene expression profiling of diffuse large B-cell lymphoma in China]
1Department of Pathology and Laboratory Medicine, Guangdong Provincial People's Hospital, Guangzhou 510080, China. yanh_liu@yahoo.com
Summary
Gene expression profiling reveals molecular subgroups within diffuse large B-cell lymphoma (DLBCL). Immunophenotyping can identify these DLBCL subtypes, suggesting non-cell-of-origin factors in pathogenesis.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Context:
- Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous lymphoid malignancy.
- Immunophenotyping is crucial for classifying DLBCL subtypes.
- Understanding molecular differences is key to targeted therapies.
Purpose:
- To perform gene expression profiling on DLBCL cases with distinct immunophenotypes.
- To correlate gene expression patterns with established immunohistochemical classifications.
- To identify molecular distinctions between DLBCL subgroups.
Summary:
- 156 DLBCL cases were subclassified using CD10, bcl-6, and MUM1 immunohistochemistry.
- Gene expression profiling was conducted on 9 DLBCLs and 3 tonsils using microarrays.
- Unsupervised clustering revealed 4 distinct groups (A, B, C, D) correlating with immunophenotypes, with Group B showing unique gene expression profiles.
Impact:
- Gene expression profiling confirms molecular subgrouping of DLBCL, identifiable by immunophenotyping.
- The distinct gene profile of Group B DLBCL suggests additional pathogenic factors beyond cell-of-origin.
- This molecular subclassification may inform more precise diagnostic and therapeutic strategies for DLBCL.
